Viatris recalls Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division
Recalled October 6, 2021 · FDA recall D-0851-2021 · Viatris
Hazard
Failed Dissolution Specifications · FDA Class II
Units
9,515 bottles
Sold at
Nationwide within the United States
Description
Failed Dissolution Specifications
Product
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Manufacturer(s)
Viatris
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →